Treatment Outcomes of Multidrug-Resistant Tuberculosis Patients in East Java, Indonesia: A Retrospective Cohort Analysis-Reference-Cited by-同舟云学术

Treatment Outcomes of Multidrug-Resistant Tuberculosis Patients in East Java, Indonesia: A Retrospective Cohort Analysis

Published:2022 Issue:3 Volume:11 Page:261
ISSN:2212-5531
Container-title:International Journal of Mycobacteriology
language:en
Short-container-title:Int J Mycobacteriol

Author:

Indarti HardiniTri,Kristin Erna,Soedarsono Soedarsono,Endarti Dwi

Publisher

Medknow

Subject

Infectious Diseases,Microbiology (medical)

Reference28 articles.

1. World Health Organization. Global Tuberculosis Report 2020. Geneva: World Health Organization; 2020. Available from: https://apps.who.int/iris/handle/10665/336069. [Last accessed on 2022 Feb 16].

2. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis;Dheda;Lancet Respir Med,2017

3. World Health Organization. WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment-Drug-Resistant Tuberculosis Treatment. Geneva: World Health Organization; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558570/. [Last accessed on 2022 Feb 16].

4. World Health Organization. Global Tuberculosis Report 2018. Geneva: World Health Organization; 2018.. Available from: https://apps.who.int/iris/handle/10665/274453. [Last accessed on 2022 Jan 31].

5. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis;Van;Am J Respir Crit Care Med,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of high-dose isoniazid-containing therapy for multidrug-resistant tuberculosis: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-01-08

2. Favorable outcome of individual regimens containing bedaquiline and delamanid in drug-resistant tuberculosis: A systematic review;International Journal of Mycobacteriology;2023

3. Early efficacy of individual regimens containing bedaquiline in patients with drug resistant tuberculosis;Asian Pacific Journal of Tropical Medicine;2023

4. Linezolid-associated neurologic toxicity in patients with drug-resistant tuberculosis in a bedaquiline-based regimen: A scoping review;Journal of Preventive, Diagnostic and Treatment Strategies in Medicine;2023

5. Scoping review: QT interval prolongation in regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis;International Journal of Mycobacteriology;2022